Endocrinology Diabetology and Metabolic Diseases, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
Institut Génétique, Reproduction & Développement (iGReD), CNRS, INSERM, University of Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Int J Environ Res Public Health. 2022 Mar 18;19(6):3606. doi: 10.3390/ijerph19063606.
Objective: Cardiovascular effects of thyroid hormones may be measured through heart rate variability (HRV). We sought to determine the impact of hyperthyroidism on HRV. Design: A systematic review and meta-analysis on the impact of hyperthyroidism on HRV. Methods: PubMed, Cochrane, Embase and Google Scholar were searched until 20 August 2021 for articles reporting HRV parameters in untreated hyperthyroidism and healthy controls. Random-effects meta-analysis was stratified by degree of hyperthyroidism for each HRV parameter: RR intervals (or Normal-to-Normal intervals—NN), SDNN (standard deviation of RR intervals), RMSSD (square root of the mean difference of successive RR intervals), pNN50 (percentage of RR intervals with >50 ms of variation), total power (TP), LFnu (low-frequency normalized unit) and HFnu (high-frequency), VLF (very low-frequency), and LF/HF ratio. Results: We included 22 studies with 10,811 patients: 1002 with hyperthyroidism and 9809 healthy controls. There was a decrease in RR (effect size = −4.63, 95% CI −5.7 to −3.56), SDNN (−6.07, −7.42 to −4.71), RMSSD (−1.52, −2.18 to −0.87), pNN50 (−1.36, −1.83 to −0.88), TP (−2.05, −2.87 to −1.24), HFnu (−3.51, −4.76 to −2.26), and VLF power (−2.65, −3.74 to −1.55), and an increase in LFnu (2.66, 1.55 to 3.78) and LF/HF ratio (1.75, 1.02 to 2.48) (p < 0.01). Most parameters had ES that was twice as high in overt compared to subclinical hyperthyroidism. Increased peripheral thyroid hormones and decreased TSH levels were associated with lower RR intervals. Conclusions: Hyperthyroidism is associated with a decreased HRV, which may be explained by the deleterious effect of thyroid hormones and TSH. The increased sympathetic and decreased parasympathetic activity may have clinical implications.
目的:甲状腺激素对心血管的影响可通过心率变异性(HRV)来衡量。我们旨在确定甲状腺功能亢进症对 HRV 的影响。
设计:一项关于甲状腺功能亢进症对 HRV 影响的系统评价和荟萃分析。
方法:检索 PubMed、Cochrane、Embase 和 Google Scholar,以获取截至 2021 年 8 月 20 日报告未经治疗的甲状腺功能亢进症和健康对照者 HRV 参数的文章。随机效应荟萃分析根据每个 HRV 参数的甲状腺功能亢进症程度进行分层:RR 间期(或正常-正常间期-NN)、SDNN(RR 间期标准差)、RMSSD(连续 RR 间期均方根差)、pNN50(RR 间期变化超过 50ms 的百分比)、总功率(TP)、LFnu(低频标准化单位)和 HFnu(高频)、VLF(极低频)和 LF/HF 比值。
结果:我们纳入了 22 项研究,共 10811 例患者:1002 例甲状腺功能亢进症患者和 9809 例健康对照者。RR 间期(效应大小=-4.63,95%CI-5.7 至-3.56)、SDNN(-6.07,-7.42 至-4.71)、RMSSD(-1.52,-2.18 至-0.87)、pNN50(-1.36,-1.83 至-0.88)、TP(-2.05,-2.87 至-1.24)、HFnu(-3.51,-4.76 至-2.26)和 VLF 功率(-2.65,-3.74 至-1.55)降低,而 LFnu(2.66,1.55 至 3.78)和 LF/HF 比值(1.75,1.02 至 2.48)升高(p<0.01)。与亚临床甲状腺功能亢进症相比,显性甲状腺功能亢进症的大多数参数的 ES 高 2 倍。外周甲状腺激素升高和 TSH 水平降低与 RR 间期缩短有关。
结论:甲状腺功能亢进症与 HRV 降低有关,这可能是甲状腺激素和 TSH 的有害作用所致。交感神经活性增加和副交感神经活性降低可能具有临床意义。
Int J Environ Res Public Health. 2022-3-18
Cochrane Database Syst Rev. 2018-2-6
Cochrane Database Syst Rev. 2022-4-26
Cochrane Database Syst Rev. 2005-7-20
Cochrane Database Syst Rev. 2022-9-27
Cochrane Database Syst Rev. 2021-9-14
Cochrane Database Syst Rev. 2025-1-29
Appl Psychophysiol Biofeedback. 2025-4-28
Nat Commun. 2023-6-7
Int J Environ Res Public Health. 2023-1-14
BMC Res Notes. 2018-11-15
Indian J Clin Biochem. 2018-4
BMC Res Notes. 2018-2-22
Korean J Intern Med. 2018-3
Front Public Health. 2017-9-28
Front Public Health. 2017-9-11